Brad Reifler’s Unique Approach to the Financial World

Brad Reifler attended Bowdoin College from 1977-1981 studying Economics and Political Science before becoming an American entrepreneur. He has served on the Boards for companies such as Genesis Securities, Foresight Research Solutions, and European American Investment Bank.

He started his first business in the 1980’s when he created Reifler Trading Company which handled hundreds of millions in discretionary accounts, then grew into execution services, institutional research, global derivative advising, and information dissemination. Reifler Trading became one of the biggest independent futures operations, and then in 2000, Brad sold the company to the world’s biggest futures company, Refco, Inc.

Brad Reifler went on and founded in 1995, Pali Capital, a company which focused on equity markets. Reifler caught on to the growth in hedge funds by ascertaining different strategies, and did it by combining top research with derivative structures and credit analysis. He then would pass on his knowledge to sales traders who would then have the ability to package the strategy and perform well.

The company did so well in the 13 years that Brad Reifler was there, that it generated over $1 billion in commission income. Pali had over 300 people employed and offices in four continents. In November of 2008, Brad retired from the company and started a new venture.

In 2009, Brad Reifler started the group, Forefront Advisory, LLC and ForeFront Partners, again creating a unique product offering, which keeps Brad very busy as Founder and CEO. While under the Forefront dome, Reifler has worked hard to bring together some of the most greatly respected and powerful business leaders to Forefront’s platform, and after 30 years of combined experience on Wall Street, continues to do so.

Some of the people serving on the board are from Fortune 100 and 500 companies, one member being the winner of what would be the Nobel Prize of Economics, in China, and yet another holds three presidential appointments.

According to Barrons, Brad Reifler still serves on several advisory and corporate boards and formerly the Trustee of the Millbrook School and Chairman of the Finance Committee. Reifler also has numerous regulatory licenses which include Series 3, 7, 24, and 63. One thing that Brad Reifler does extremely well is having a unique perspective when it comes to the financial world and it has paid off.

Jim Tananbaum Introduces Molly He to Foresite Capital for A Better Health Care System

Foresite Capital recently announced its new development on an additional staff member. It is undisputed that for an organization to prosper in business, sometimes new blood with exceptional talent will serve a great purpose. The introduction of Dr. Molly He to Foresite Capital will be a great stride of success to the healthcare sector. She brings to Foresite Capital fifteen years of experience in the medical care industry.


According to INC42, the chief executive officer of Foresite Capital, Molly He’s experience will be useful in developing drugs for patients through his company. Dr. He brings to Foresite in –depth scientific research and results on genomics and drug development. Jim Tananbaum added that her excellence in leadership would be valuable to Foresite Capital because the company is looking forward to diversifying its operations and portfolios in transformational ways. She is an alumnus of Illumina. She was the scientist in charge of Illumina’s protein reagent innovation as well as improvements.


In an article on Biz Journals, before she joined Illumina, Molly was in charge of sciences at the Pacific Biosciences company. In this company, she was in charge of the reagent development in the department of single molecular sequencing chemistry. She spent her first ten years of career in the industry of pharmaceuticals. Her focus was based on the organic base and design of antibody. She worked on cancer-related drugs.

Jim’s Profile

Jim Tananbaum is a career executive and entrepreneur. He is the chief executive officer of Foresite Capital, a firm that is dedicated to building healthcare leaders by offering financial support. Before joining Foresite Capital, he was a founding partner at Prospect Ventures Partners. With Foresite Capital as his main success story, Jim has been the talk of the Midas list on Forbes. Three times in a row, he has made it through public recognition. Other investments that have contributed to this recognition are Amira Pharmaceuticals, Amerigroup, and Jazz Pharmaceuticals. At Foresite Capital, he has diversified the portfolio of the company to cover patients and physicians. Under his insight, Foresite Capital has partnered with organizations committed to making the health care sector a better service provider.

Click here:

PodcastOne’s Norman Pattiz Announces Results Of Podcast Advertising Study

The Executive Chairman of PodcastOne, Norman Pattiz recently announced the results of a podcast advertising study. The study was completed by Edison Research and looked at how effective podcast advertising was on consumers ability to recall a brand as well as its message, and also the effect on their intentions of buying the brand being advertised.

The study involved interviewing consumers before and after the ad campaign of five major national brands in order to measure the effectiveness of the ads.

Norman Pattiz said that there were a number of key findings. Among the largest, only 7% of listeners made mention of a particular grocery brand before the study while 60% mentioned it afterwards, greatly increasing brand awareness.

A car aftermarket product was viewed “very favorably” by only 18% before while 33% felt that way after the ad campaign for it had run on a podcast. For another car aftermarket product, awareness of the brand increased by 60% while a casual dining restaurant went up by 76%. This all shows that advertising on podcasts is very effective.

In addition to founding PodcastOne, Norman Pattiz is the founder of Westwood One. He founded Westwood One in the late 70’s and developed it into the largest provider of radio content in the United States.

In addition to talk, entertainment, news, and traffic, under Norman Pattiz’s leadership they also broadcast the largest sports events in the world such as both the Summer and Olympic games, Super Bowls, and March Madness. He has also launched other media companies such as Courtside Entertainment Group.

It was in 2013 that Norman Pattiz launched PodcastOne. The idea came to him after he met Kit Gray and found out he was a representative for people’s podcasts. The thought occurred to him that what Kit Gray was doing sounded very similar to what he had been doing at Westwood One, basically the internet version of it.

He started signing a lot of nationally known talent and over the last four years has built PodcastOne into the largest podcast provider in the industry. As he runs a lean company, he is involved in everything the company does whether its acquiring talent, marketing, selling ads, and everything in between.

One of his favorite things about the industry is that it’s very democratic. There are no gatekeepers standing in the way between people and the content they seek.

Learn more about Norman Pattiz:

Why Stem Cell Therapy Is the Best Alternative Treatment for Lung Diseases

Stem cell therapy for lungs has become a hot topic of discussion in recent years. With the ever-rising cases of disease-ridden patients, researchers have deemed it necessary to develop cutting-edge and innovative therapies aimed at providing long-lasting treatment to diseases such as pulmonary fibrosis, bronchiolitis obliterans, cystic fibrosis and much more. Apart from the conventional methods of treatment, lung transplants have become have become a viable and better alternative compared to counterpart therapies.

The primary focus area has been shifted to the following critical elements with the sole intention of eradicating various lung disorders:

  • Stem cell engineering: To obtain a better understanding of the effectiveness of lung-related clinical applications, researchers have above and beyond to generate IPS cells from fibroblasts tissues of infected patients. According to PR Web, such a study can differentiate specific pulmonary epithelial cells critical in promoting cell therapy.
  • Recellularization of decellularized lungs: Researchers have delved into studying lung Decellularization and Recellularization with the sole intention of supporting the production of patient-specific tested lungs. In basic terms, lung decellularization involves extracting all cells from a donor’s lung while just leaving enough that can be repopulated from the patient’s cells.

Based on successful results from animal subjects, researchers have shifted attention to recellularizing human lungs. Alternatively, adequate statistics shed light into matrix fragments to determine how retrieved cells can be differentiated into various types of lung cells.

For patients in need, stem cell therapy general commands a $10,000 cost tag per treatment. Quite expensive to the ordinary man, but adequate arrangements can be made to simplify the payment process with an eye on medical service delivery. According to Cedars-Sinai experts, in most cases, patients undergo more than one non-FDA approved treatments to conduct treatment efficiently. On the other hand, invalids can also receive high-quality health services at a reduced price range of $7000-$8000.

The Lung Institute in Brief

The Lung Institute is widely considered to be a premium provider of stem cell therapies for various lung diseases. With over a century worth of experience, in-house experts have become adept at providing unmatched services to their diverse range of clients. With a world-class facility at their disposal, such specialists have deployed cell transplants using cutting technology uniquely designed to deliver excellent results.

The prominent Institute operates from various locations such as Tampa, Nashville, Scottsdale, Dallas, and Pittsburgh.

Securus Technologies Moves On Its Path To Success

In case any jail or prison officials are asked about the first name that comes to their mind with regard to phone services for the inmates, they would say Securus Technologies.


This is because Securus Technologies understands its customers well. They are constantly asking for feedback from their customers and incorporating it in their products and services. In fact, I have been told that nearly every week, Securus Technologies is coming out with a new product, a new service or some kind of an innovative feature on its existing product.


Rather, Securus Technologies is the only company that is asking its existing customers as well as the prospective ones to visit their facility that is in Texas. It is an open invitation. They can visit any time. Basically, I understand very well what Securus Technologies is trying to do here. This is their way of informing the officials at the prison facilities about the products that are available for them to use. Besides, they would be explained how to use these products and services in the best possible way. Any features or special attributes will be well explained by the people here at Securus Technologies. In addition, they would be told how these attributes can help them in performing their functions well.


I do remember when some prison officials had called Securus Technologies to ask about their covert feature. At that time the authorities were busy in some investigation. They understood the usage of this feature and made use of it in their investigation too. This helped them to catch hold of the culprit and get a search warrant for the corrupt official. This also helped in apprehending the contraband. This way Securus Technologies is able to nab criminals and enhance safety. This way they are able to make the facility safe for the inmates.